Our assumption that PACAP could act as an important growth regulator of NE GI tumours is supported by the fact that PACAP has been found to modulate rat gastric ECL cell proliferation, a cell type which during malignant transformation gives origin to gastric carcinoid tumours (Läuffer et al, 1999). Here, ADCYAP1 is linked to gastric neuroendocrine tumor G1.